e7449
Small moleculeexperimental
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
2
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Jan 1, 2012 (NCT01618136)
Timeline
2010s
- Jan 1, 2012
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Poly [ADP-ribose] polymerase 4INHIBITOR
PARP4 inhibitor
- Tankyrase-1INHIBITOR
TNKS inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- e7449
- e7449
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02396433 | Phase 1/Phase 2 (Phase 2) | Apr 1, 2015 | University of Texas, San Antonio |
| NCT01618136 | Phase 1/Phase 2 (Phase 2) | Jan 1, 2012 | Eisai |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Eisai | For profit | 1 | 1 | 1 | 2012 |
| University of Texas, San Antonio | Academic/Hospital | 1 | 1 | 1 | 2015 |
2 organizations
Page 1 / 1